HAL will be down for maintenance from Friday, June 10 at 4pm through Monday, June 13 at 9am. More information
Skip to Main content Skip to Navigation
Journal articles

Cancer and RASSF1A/RASSF1C, the two faces of Janus.

Abstract : Although encoded by the same gene, RASSF1A and RASSF1C are two opposites in carcinogenesis; one is a tumor suppressor that is silenced in a plethora of cancers, while the other is an oncogene that remains unaffected. Here, we aim to understand why and to highlight their respective clinical implications.
Document type :
Journal articles
Complete list of metadata

Contributor : Carole Brunaud Connect in order to contact the contributor
Submitted on : Thursday, October 10, 2019 - 9:12:17 AM
Last modification on : Wednesday, March 30, 2022 - 3:23:57 AM



Fatéméh Dubois, Emmanuel Bergot, Guénaëlle Levallet. Cancer and RASSF1A/RASSF1C, the two faces of Janus.. Trends in Cancer, Cell Press, 2019, 5 (11), pp.662-665. ⟨10.1016/j.trecan.2019.10.001⟩. ⟨hal-02310265⟩



Record views